Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-018-2691-8
Abstract: BackgroundOxaliplatin (OXA) is a cornerstone in the treatment of colorectal cancer (CRC). Retreatment with OXA is frequently considered as salvage treatment. OXA-induced neuropathy (OIN) is the most frequent and feared long-term side effect.Patients and methodsCRC… read more here.
Keywords: retreatment; colorectal cancer; cancer; oxa based ... See more keywords